Per-Erik Sandlund new CEO of SwedenBIO

29-Aug-2005
SwedenBIO has appointed Per-Erik Sandlund, former CEO of Amersham Biosciences, as new CEO. He will be succeding Dr. Hans Nyctelius who has recently been appointed as COO of Q-Med, one of the largest biotech companies in northern Europe. "SwedenBIO has, under the leadership of Dr Nyctelius, in a very short time established a strong support and today has about 110 member companies" says Björn Nilsson, chairman of SwedenBIO. "I want to thank Hans profoundly for this extraordinary achievement. Per-Erik Sandlund with his long industrial experience has the right expertise to take SwedenBIO to the next level."

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances